Will Pfizer/BioNTech And Moderna Stay Atop The COVID-19 Vaccine Market Forever?

Almost as soon as COVID-19 vaccines became available, their recipients became either “Team Pfizer” or “Team Moderna,” while competing products from AstraZeneca PLC and Johnson & Johnson quickly fell by the wayside. Novavax, Inc.’s protein-based vaccine has likewise not really caught on. But while Pfizer Inc./BioNTech SE’s Comirnaty and Moderna, Inc.’s Spikevax have quickly come to dominate the market, a panelist at the BIO CEO & Investor Conference in New York said there is still room for additional competitors despite the typical market dynamics for traditional vaccines.

Aerium Therapeutics CEO Rajeev Venkayya, who had previously served as president of the Global Vaccine Business Unit of Takeda...